HFA-ICOS Baseline Cardio-Oncology Risk (Multi-targeted Kinase Inhibitors/CML) is a risk scores tool commonly applied in Cardio-Oncology. Baseline cardio-oncology risk assessment for selected kinase inhibitor therapies. Use the interactive calculator for inputs, limitations, and primary references.

Not a substitute for clinical judgment. Verify critical values with primary literature, local protocols, and specialist input when appropriate.